July 23, 2014 10:17 AM ET

Pharmaceuticals

Company Overview of KAI Pharmaceuticals, Inc.

Executive Profile

Steven P. James

AgeTotal Calculated CompensationThis person is connected to 1 Board Members in 1 different organizations across 5 different industries.

See Board Relationships
----

Background

Mr. Steven P. James, known as Steve, has been President and Chief Executive Officer of KAI Pharmaceuticals, Inc. since October 15, 2004. Mr. James served as Senior Vice President of Commercial Operations at Exelixis, Inc., from June 10, 2003 to September 15, 2004, where he was responsible for managing and expanding Exelixis business development and corporate development activities. At Exelixis, Mr. James played a critical role in developing corporate strategy for business ...

Corporate Headquarters

270 Littlefield Avenue
South San Francisco, California 94080-6924

United States

Phone: 650-244-1100
Fax: 650-244-1199

Board Members Memberships

Chief Executive Officer, President and Executive Director
Director

Education

Bachelor's Degree
Brown University
Master's Degree
J.L. Kellogg School of Management, Northwestern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
$1.5M
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$1.9M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
$3.0M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAI Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.